Understanding antimicrobial pharmacokinetics in critically ill patients to optimize antimicrobial therapy: A narrative review
Author:
Open Access
- 29 February 2024
- journal article
- review article
- Published by Elsevier in Journal of Intensive Medicine
- Vol. 4 (3) , 287-298
Abstract
No abstract availableKeywords
This publication has 138 references indexed in Scilit:
- Practical considerations for individualizing drug dosing in critically ill adults receiving renal replacement therapyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2023
- Continuous vs Intermittent Meropenem Administration in Critically Ill Patients With SepsisJAMA, 2023
- Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trialIntensive Care Medicine, 2022
- Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#Intensive Care Medicine, 2020
- Effect of adjunctive tobramycin inhalation versus placebo on early clinical response in the treatment of ventilator-associated pneumonia: the VAPORISE randomized-controlled trialIntensive Care Medicine, 2020
- International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2019
- Understanding PK/PDIntensive Care Medicine, 2015
- Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI studyIntensive Care Medicine, 2015
- Determinants of drug absorption in different ECMO circuitsIntensive Care Medicine, 2010
- Mini-series: I. Basic science. Uncertainty and inaccuracy of predicting CYP-mediated in vivo drug interactions in the ICU from in vitro models: focus on CYP3A4Intensive Care Medicine, 2009